Duke Energy vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 82)

Duke Energy

LeaderEnergy & Utilities

Enterprise

Charlotte NC regulated utility (NYSE: DUK) ~$29B revenue; 8.4M electric customers, Carolinas load growth 8x prior trend from semiconductor/data center boom, 4,000 MW solar by 2034, competing with NextEra and Southern Company.

AI VisibilityBeta
Overall Score
A82
Category Rank
#68 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
87
Perplexity
77
Gemini
83

About

Duke Energy Corporation is a Charlotte, North Carolina-based regulated electric utility holding company — publicly traded on the New York Stock Exchange (NYSE: DUK) as an S&P 500 Utilities component — serving approximately 8.4 million electric customers and 1.7 million natural gas customers across the Carolinas, Florida, Indiana, Ohio, and Kentucky through regulated subsidiary utilities including Duke Energy Carolinas, Duke Energy Progress (North and South Carolina), Duke Energy Florida, and Duke Energy Indiana/Ohio/Kentucky, through approximately 28,000 employees. Duke Energy is one of the largest regulated utilities in the United States with approximately $29 billion in annual revenue, managing a generation fleet spanning nuclear, natural gas, coal (transitioning to retirement), solar, and wind across a 100,000-square-mile service territory. CEO Lynn Good, who has led Duke Energy since 2013, filed the company's 2025 Carolinas Resource Plan responding to unprecedented load growth — North Carolina attracted $19 billion in announced business investments and 25,000+ new jobs in 2025 alone, driven by semiconductor manufacturing, data center construction, and electric vehicle manufacturing — resulting in electricity demand growth projections 8x greater than the prior 15-year trend. The plan calls for 4,000 megawatts of solar capacity by 2034 and battery storage expansion to 5,600 megawatts by 2034 (+2,900 MW from current levels).

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

82
Overall Score
90
#68
Category Rank
#9
58
AI Consensus
60
stable
Trend
stable
87
ChatGPT
99
77
Perplexity
99
83
Gemini
83
75
Claude
96
92
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.